NCT07480902 2026-03-18
Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer
Timser SAPI de CV
Phase NA Recruiting
Clinical Trials
7 trialsNCT07211204 2026-03-03
Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population
Timser SAPI de CV
Phase NA Withdrawn
NCT00896480 2021-04-08
Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous Melanoma
GlaxoSmithKline
Phase 2 Completed
NCT01149343 2020-11-20
Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer
GlaxoSmithKline
Phase 1 Completed
NCT00973362 2017-01-06
Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System
Gen-Probe, Incorporated
Phase 3 Completed
NCT02689726 2016-12-02
Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL
Genticel
Phase 1 Terminated
NCT00312286 2016-09-23
Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
Takeda
Phase 2 Terminated